相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial
Joao Pedro Ferreira et al.
CLINICAL RESEARCH IN CARDIOLOGY (2021)
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death
Damien Bertheloot et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
TRAIL and Cardiovascular Disease-A Risk Factor or Risk Marker: A Systematic Review
Katarzyna Kakareko et al.
JOURNAL OF CLINICAL MEDICINE (2021)
PRISMA 2020: An Update
Martha K. Swartz
JOURNAL OF PEDIATRIC HEALTH CARE (2021)
Targeting apoptosis in cancer therapy
Benedito A. Carneiro et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)
Parimal Samir et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
sTRAIL-R2 (Soluble TNF [Tumor Necrosis Factor]-Related Apoptosis-Inducing Ligand Receptor 2) a Marker of Plaque Cell Apoptosis and Cardiovascular Events
Isabel Goncalves et al.
STROKE (2019)
Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation
Miles A. Tanner et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation
Winnie Chua et al.
EUROPEAN HEART JOURNAL (2019)
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease
Tobias Feldreich et al.
JOURNAL OF NEPHROLOGY (2019)
Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis
Maria Wigren et al.
ATHEROSCLEROSIS (2018)
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
Christoph Nowak et al.
DIABETOLOGIA (2018)
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease
Maria Vittoria Arcidiacono et al.
PLOS ONE (2018)
GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction
Emma Skau et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction A Holistic Proteomic Approach
Camilla Hage et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2017)
Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease
Ingrid Yao Mattisson et al.
EBIOMEDICINE (2017)
Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms
Batmunkh Bumdelger et al.
PLOS ONE (2016)
Low serum TNF-related apoptosis-inducing ligand (TRAIL) levels are associated with acute ischemic stroke severity
Yang Ho Kang et al.
ATHEROSCLEROSIS (2015)
Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke
Xudong Pan et al.
PLOS ONE (2015)
Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation
Krzysztof Rewiuk et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments
Carson Ka-Lok Lo et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Association of post-cardioversion transcardiac concentration gradient of soluble tumor necrosis factor-related apoptosis-inducing ligand (sTRAIL) and inflammatory biomarkers to atrial fibrillation recurrence
Spyridon Deftereos et al.
CLINICAL BIOCHEMISTRY (2013)
Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents
Katsuhito Mori et al.
CYTOKINE (2013)
A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure
Bernhard Richter et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Increased Preoperative Serum Apoptosis Marker Fas Ligand Correlates with Histopathology and New-Onset of Atrial Fibrillation in Patients After Cardiac Surgery
Patrick Mueller et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2013)
Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome Patients
Pavel Osmancik et al.
PLOS ONE (2013)
TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
Belinda A. Di Bartolo et al.
PLOS ONE (2013)
Soluble Tumor Necrosis Factor Related Apoptosis Inducing Ligand Level as a Predictor of Severity of Sepsis and the Risk of Mortality in Septic Patients
Ye Tian et al.
PLOS ONE (2013)
TRAIL shows potential cardioprotective activity
Barbara Toffoli et al.
INVESTIGATIONAL NEW DRUGS (2012)
Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension
Abdul G. Hameed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults
Stefano Volpato et al.
ATHEROSCLEROSIS (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Decreased Apoptosis following Successful Ablation of Atrial Fibrillation
Pavel Osmancik et al.
CARDIOLOGY (2010)
Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
Shreenidhi M. Venuraju et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients
Sophie Liabeuf et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia
Min Cui et al.
NEUROBIOLOGY OF DISEASE (2010)
Prognostic value of apoptosis markers in advanced heart failure patients
Alexander Niessner et al.
EUROPEAN HEART JOURNAL (2009)
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice
Paola Secchiero et al.
CIRCULATION (2006)
The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology
Giorgio Zauli et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease
A Boldt et al.
HEART (2004)
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells
P Secchiero et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L
R Di Pietro et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells
C Tecchio et al.
BLOOD (2004)